idiotypic vaccines (Biomira)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameidiotypic vaccines (Biomira)
Drug Alias NameB-cell lymphoma vaccine (Biomira/NCI)B-cell lymphoma vaccine (Biomira/NCI)
ClassificationBiologics > Protein drugs > Recombinant polypeptideVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsLymphoma, Non-HodgkinLymphomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBiomira USA Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiovector Therapeutics SABiomira USA IncCascadian Therapeutics Inc +[4] 
Active IndicationsN/A
Inactive IndicationsLymphoma, Non-HodgkinLymphomaNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A